Mitsubishi UFJ Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-84,504
Closed -$15.5M 1137
2021
Q2
$15.5M Buy
84,504
+11,328
+15% +$2.08M 0.08% 261
2021
Q1
$11.2M Buy
73,176
+10,105
+16% +$1.55M 0.07% 302
2020
Q4
$9.85M Buy
63,071
+2,950
+5% +$461K 0.08% 283
2020
Q3
$6.88M Buy
60,121
+9,375
+18% +$1.07M 0.06% 313
2020
Q2
$5.7M Buy
50,746
+6,757
+15% +$758K 0.07% 302
2020
Q1
$3.95M Sell
43,989
-614
-1% -$55.1K 0.06% 304
2019
Q4
$4.75M Buy
44,603
+5,496
+14% +$585K 0.06% 314
2019
Q3
$3.83M Buy
39,107
+1,712
+5% +$168K 0.06% 306
2019
Q2
$4.9M Buy
37,395
+7,410
+25% +$971K 0.08% 243
2019
Q1
$4.05M Buy
29,985
+1,651
+6% +$223K 0.08% 236
2018
Q4
$2.84M Sell
28,334
-1,574
-5% -$158K 0.07% 265
2018
Q3
$4.16M Sell
29,908
-325
-1% -$45.2K 0.09% 225
2018
Q2
$3.75M Sell
30,233
-273
-0.9% -$33.9K 0.08% 237
2018
Q1
$3.4M Sell
30,506
-4,088
-12% -$456K 0.08% 255
2017
Q4
$4.32M Buy
34,594
+1,293
+4% +$162K 0.09% 224
2017
Q3
$4.67M Buy
33,301
+995
+3% +$140K 0.11% 197
2017
Q2
$3.93M Sell
32,306
-3,731
-10% -$454K 0.1% 219
2017
Q1
$4.37M Buy
36,037
+1,323
+4% +$160K 0.1% 214
2016
Q4
$4.26M Buy
34,714
+171
+0.5% +$21K 0.1% 208
2016
Q3
$4.23M Buy
34,543
+879
+3% +$108K 0.11% 201
2016
Q2
$3.93M Buy
33,664
+908
+3% +$106K 0.1% 203
2016
Q1
$4.56M Buy
32,756
+2,736
+9% +$381K 0.12% 169
2015
Q4
$5.73M Buy
30,020
+1,933
+7% +$369K 0.17% 124
2015
Q3
$4.39M Sell
28,087
-81
-0.3% -$12.7K 0.14% 142
2015
Q2
$5.09M Buy
28,168
+1,505
+6% +$272K 0.16% 127
2015
Q1
$4.62M Sell
26,663
-1,426
-5% -$247K 0.14% 157
2014
Q4
$5.24M Sell
28,089
-3,890
-12% -$726K 0.16% 137
2014
Q3
$5.3M Sell
31,979
-6,503
-17% -$1.08M 0.16% 141
2014
Q2
$6.01M Buy
38,482
+51
+0.1% +$7.97K 0.15% 153
2014
Q1
$5.85M Buy
38,431
+2,403
+7% +$366K 0.16% 153
2013
Q4
$4.75M Sell
36,028
-9,056
-20% -$1.19M 0.14% 169
2013
Q3
$5.24M Buy
45,084
+2,384
+6% +$277K 0.14% 169
2013
Q2
$3.94M Buy
+42,700
New +$3.94M 0.11% 214